Blog

Enveda Biosciences has raised $311 million to drive AI-based drug development, focusing on nature-derived treatments for skin issues and weight management.

Alphabet's $85 billion stock sale highlights rising investor confidence in AI technology. This move could reshape market dynamics and innovation strategies.

Altara's recent $7M funding aims to eliminate data silos in physical sciences by leveraging AI to streamline R&D processes and improve data accessibility.

ComfyUI achieves a $500 million valuation, raising $30 million. The platform empowers creators with tools for AI-generated media control and ownership.

Cognichip's recent $60M funding aims to revolutionize chip design, cutting costs by 75% and timelines by half. Could this be the future of AI-powered technology?

Didero has secured $30M in funding to revolutionize manufacturing procurement by introducing an AI-driven automation layer that enhances efficiency and responsiveness.